Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Psicologia, Reflexao E Critica : Revista Semestral Do Departamento De Psicologia Da UFRGS|February 7, 2020
Needs assessment for cultural adaptation of Strengthening Families Program (SFP 10-14-UK) in BrazilSheila Giardini Murta, Larissa de Almeida Nobre-Sandoval, Marina de Souza Pedralho, et al.Breast Cancer Research and Treatment|October 8, 2020
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevantKarina Cox, Nicky Dineen, Sian Taylor-Phillips, et al.Journal of Oncology Practice|August 11, 2017
Improvements in Patient and Health System Outcomes Using an Integrated Oncology and Palliative Medicine Approach on a Solid Tumor Inpatient ServiceRichard F Riedel, Kim Slusser, Steve Power, et al.Investigational New Drugs|March 22, 2016
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancerShivaani Kummar, James L Wade, Amit M Oza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Cediranib for metastatic alveolar soft part sarcomaShivaani Kummar, Deborah Allen, Anne Monks, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumorsShivaani Kummar, Mark Raffeld, Lamin Juwara, et al.European Journal of Cancer (Oxford, England : 1990)|January 21, 2011
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasShivaani Kummar, Martin E Gutierrez, Alice Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomasShivaani Kummar, Jiuping Ji, Robert Morgan, et al.Neuro-Oncology|May 12, 2004
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant gliomaJennifer A Quinn, David A Reardon, Allan H Friedman, et al.Cancer Chemotherapy and Pharmacology|May 13, 2016
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumorsShivaani Kummar, Alice Chen, Martin Gutierrez, et al.Pageof 8